Sorularınız için bize ulaşın: +90(312)4728786
  • EN

Elis İlaç | Türkiye İlaç Deposu | Elis İlaç Tedarikçisi | Elis İlaç Deposu

Elis İlaç | Türkiye İlaç Deposu | Elis İlaç Tedarikçisi | Elis İlaç Deposu

Elis Ilac Company Hakkında

T +90 (312) 472 87 86
Email: sales@elisilac.com

Elis Ilac
Ahmet Taner Kışlalı Mah. 2879. Sokak. Park Evleri Sitesi 2/2 Çayyolu-Çankaya-Ankara/TURKEY

  • Anasayfa
  • Ürünler
  • Hizmetlerimiz
  • Hakkımızda
  • Etkinlikler
  • Blog
  • Bize Ulaşın
Bize Sorun?
  • Anasayfa
  • News
  • Rare diseases: Over 300 million patients affected worldwide
Eylül 21, 2023

Rare diseases: Over 300 million patients affected worldwide

Rare diseases: Over 300 million patients affected worldwide

by arioadmin / Pazartesi, 28 Ekim 2019 / Published in News
rare-diseases-s

Rare diseases represent a global problem. Until now, the lack of data made it difficult to estimate their prevalence. Created and coordinated by Inserm, the Orphanet database, which contains the largest amount of epidemiological data on these diseases taken from the scientific literature, has made it possible to obtain a global estimate. Under the coordination of Inserm US14 Director Ana Rath, these data have shown that more than 300 million people worldwide are currently living with a rare disease. The study, published in the European Journal of Human Genetics, is the first to analyze the available data on rare diseases with such precision.

Systemic sclerosis, polycythemia vera and Marfan syndrome… These are obscure conditions, which are still largely unknown by the general public and differ broadly in their clinical expression. They do have one thing in common: they are very rare.

According to the European definition, a disease is considered rare when it affects fewer than 5 in 10,000 people. Few studies have been performed by the scientific community, and there is a lack of health professional expertise and of suitable treatments. This means that the thousands of rare diseases identified over the years cause immense suffering to many patients and their families, throughout the world.

The few epidemiological studies published on the subject so far rarely use general population registries. This made it difficult to establish their exact prevalence.

Yet such figures are needed if we are to identify priorities for health and research policy, understand the societal burden of these diseases, adapt the management of patients and, more generally, promote a real public health policy for rare conditions. “Given that little is known about rare diseases, we could be forgiven for thinking that their sufferers are thin on the ground. But when taken together they represent a large proportion of the population. Although rare diseases are individual and specific, what they have in common is their rarity, and the consequences which result from that”, emphasizes Ana Rath, from Inserm US14 (Information and service platform for rare diseases and orphan drugs).

Under her leadership, study author Stéphanie Nguenguan (Inserm US14), and her colleagues, used the Orphanet database to shed light on the issue.

 

0
  • Tweet
Tagged under: research

About arioadmin

What you can read next

FDA update generic drugs
Drugs Approved by FDA in 2019
dopaminergic-neuron
New strategy to treat Parkinson’s disease
blood pressure medication
Bed time is the best time to take blood pressure medication

Bir cevap yazın Cevabı iptal et

E-posta hesabınız yayımlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir

Recent Posts

  • world_population_density

    4% of the world’s population

    Created in 1997 by Inserm, Orphanet has progres...
  • dopaminergic-neuron

    New strategy to treat Parkinson’s disease

    Northwestern Medicine scientists have used pati...
  • blood pressure medication

    Bed time is the best time to take blood pressure medication

    People with high blood pressure who take all th...
  • FDA update generic drugs

    Drugs Approved by FDA in 2019

    Balversa (erdafitinib); Janssen Oncology; For t...
  • news

    Pass savings along to customers and clients with wholesale pharmaceuticals

    Pharmaceutical wholesale products provide savin...

Son Yorumlar

    Archives

    • Ekim 2019

    Categories

    • Articles
    • News
    • Scientific

    Meta

    • Giriş
    • Yazılar RSS
    • Yorumlar RSS
    • WordPress.org

    Featured Posts

    • world_population_density

      4% of the world’s population

      0 comments
    • dopaminergic-neuron

      New strategy to treat Parkinson’s disease

      0 comments
    • blood pressure medication

      Bed time is the best time to take blood pressure medication

      0 comments
    • FDA update generic drugs

      Drugs Approved by FDA in 2019

      0 comments
    • news

      Pass savings along to customers and clients with wholesale pharmaceuticals

      0 comments

    ASK FOR YOUR ORDER

    Please fill this for and we'll get back to you as soon as possible!

    Haber Bültenimize Kayıt olun!

    Haber bültenimize üye olarak her zaman en güncel haberlere ulaşabilirsiniz.

    Spam Göndermiyoruz!

    Bize Ulaşın

    T +90 (312) 472 87 86
    Email: sales@elisilac.com

    Elis Ilac
    Ahmet Taner Kışlalı Mah. 2879. Sokak. Park Evleri Sitesi 2/2 Çayyolu-Çankaya-Ankara/TURKEY

    Google Haritalarda Görüntüle

    • SOSYAL MEDYA
    Elis İlaç | Türkiye İlaç Deposu | Elis İlaç Tedarikçisi | Elis İlaç Deposu

    © 2023 Tüm hakları saklıdır. Elis Ilac.

    ÜSTE